Postgraduate Fellow
Xiaoting Yang is the Investment Manager at Haier Biomedical, a leading service provider of digital solutions for life sciences and medical innovation through IoT transformation. In her previous role as Strategic Director of Haier Hematologi, she played a pivotal role in the strategic planning and merger integration of various new industries, including blood component separation and application, biological reagents, and scientific analytical instruments for Haier Biomedical.
With a strong foundation in molecular biology, Ms. Yang holds a master’s degree in Bioengineering from Ocean University of China. She also has hands-on experience in research and development for in vitro diagnostics (IVD).
Site: BrazilProject Title: Implementation of Metagenomic Surveillance in Wastewater for Monitoring SARS-CoV-2 and Other Pathogens in Salvador, Brazil